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Abstract 
Formalised advanced pharmacy practice is needed now more than ever for pharmacists to be 
able to competently manage increasingly complex patient services and demanding healthcare 
needs.  
Principally spearheaded by the International Pharmaceutical Federation, global efforts are 
guiding the development of foundation and advanced frameworks and facilitating their 
implementation.  
Australian action on practitioner development is largely aligned with international goals, but 
challenges remain in the face of establishing a sustainable national formal credentialing 
pathway.  
This paper reports on the latest global and local developments and discusses the opportunities 
available to continue to advance this agenda in line with global targets. 
Background 
Defined advancement of pharmacy practice is a global imperative in order to meet and fulfil 
the increasingly complex needs of patients in the changing healthcare landscape. These 
changes require pharmacists to provide more complex services and to take on clinically-
oriented roles that are more advanced, extended and specialised than current entry level 
practice scopes. In addition to direct patient care, these extended roles are associated with 
leading and educating the wider pharmacy workforce, as well as undertaking research and 
evidence-based interventions in medicine management. [1]  
In 2015, the International Pharmaceutical Federation Education (FIPEd) published a global 
report on advanced and specialised practice. [2] It is the first publication of its kind to 
examine the needs for professional recognition of advanced pharmacy practice worldwide.  
For the workforce to be able to competently cater for complex health needs, the report states 
that “pharmacists will need clear professional developmental pathways from foundation 
practice to established practice which is more advanced, and to have the opportunity to be 
formally recognised along the continuum of practitioner development”. The report also 
emphasises the benefits of recognising advanced-level pharmacists which includes improved 
patient safety and better health outcomes through the effective management of complex cases 
in expert practice areas.  
Many aspects of the report are highly consistent with Australian thinking on practitioner 
development, and there is a significant level of resonance with outputs from the Pharmacy 
Practitioner Development Committee (PPDC, formerly known as the Advanced Pharmacy 
Practice Steering Committee) such as the Advanced Pharmacy Practice Framework (APPF). 
[3] In the twelve months since the release of the FIP report [2] there has been substantial 
global and local activity relating to advanced practice, and it is timely to reflect on the role of 
the Society of Hospital Pharmacists of Australia (SHPA) in the progression of this agenda, 
across the spectrum of foundation through advanced practice.  
Foundation Practice 
It is widely recognised that pharmacists are required to demonstrate appropriate levels of 
foundation practice before acquiring the competencies and capabilities needed to be 
considered specialised or advanced practitioners. [2] There are two principal reasons for this; 
firstly, early career specialisation is now generally considered a poor strategy (for all 
healthcare professionals) which undermines workforce flexibility. Secondly, urgent health 
system needs are focussed on community care, and clinically managing an increasing 
proportion of complex patients across a spectrum of co-morbidities. [4]  
In their 2013 report to the UK’s Royal Pharmaceutical Society (RPS), “Professional 
Recognition and Professional Advancement”, the Joint Partners Credentialing Task group 
identified that the ability of healthcare professionals to enhance patients’ quality of life and 
therapeutic outcomes, and to advance scientific and public health imperatives, depends on a 
solid foundation of capability and competency built during initial education and experiential 
training. [5] The necessity for pharmacists to be supported by programmes targeting 
foundation in addition to advanced and speciality practice has also been highlighted by the 
recent launch and publication of the FIP Workforce Development Goals (WDGs). [6] The 
WDGs are a pro-active, and shared, response to the need to develop a flexible and competent 
global workforce that will meet the needs of patients in complex health care systems. The 
WDGs provide a framework for global and national action planning for pharmacy workforce 
development. Two of the WDGs are particularly pertinent to this discussion: WDG 2: 
‘Foundation training and early career development’, and WGD 4: ‘Advanced and specialist 
expert development’. 
The adaptation of the United Kingdom’s General Level Competency Framework [7] (later to 
become the RPS Foundation Practice Framework) in Australia facilitated a needs-based 
learning response to practitioner development, and was shown to improve and support 
clinical performance of pharmacists. [8] This led to SHPA implementing a national tool, the 
Clinical Competency Assessment Tool (clinCAT) to guide the development of consistent 
general level or foundation practice. [9, 10] SHPA has significantly advanced the national 
agenda for foundation training, with the forthcoming introduction (in 2017) of a structured, 
formalised and accredited two-year residency programme for pharmacists; the programme 
aims to produce competent general level pharmacists who are prepared to progress along the 
advanced practice continuum. The APPF has been adopted as the Competency Framework 
for SHPA Residency Programmes with the expectation that residents will demonstrate 
performance at the Transition level in all domains by the completion of the programme. The 
clinCAT will be utilised to provide feedback to residents on their clinical practice, and their 
wider impact and experience will be mapped against the competencies in the five APPF 
domains and documented in a personal portfolio. (See Figure 1).  
Advancing Practice 
The clinical decision-making and patient care abilities of advanced pharmacy practitioners 
are recognized to be at significantly higher levels than those of entry-level pharmacists. [2] 
To further support advanced practitioners in delivering optimal patient care, there is a need 
for formal recognition of advanced practice and for competency development frameworks 
that support the progression of advanced and speciality pharmacists. Evaluation of 
competency development frameworks in pharmacy education has recommended developing a 
formal structure to offer support of post-registration pharmacists through mentoring and 
supervision. [4, 11] This has been reinforced by FIP’s WDG 4: ‘Advanced and specialist 
expert development’, which maintains that Countries/Territories and Member Organisations 
should have “education and training infrastructures in place for the recognised advancement 
of the pharmacy workforce as a basis for enhancing patient care and health system 
deliverables” (See Table 1). [6]  
In the period 2010 to 2016 the Australian pharmacy profession made great progress in the 
development and implementation of a practitioner development pathway. This included a 
survey to gauge the perspective of the Australian pharmacy profession with respect to 
advanced practice recognition, the results of which demonstrated a clear preference for 
assessment by submission of a professional portfolio and the desire for a credential to 
recognise advanced practice. [12] The APPF was published in October 2012, and the 
Australian Pharmacy Council (APC) was endorsed in December 2013 as the independent 
entity being responsible for the credentialing of advanced practitioners in Australia. In 2014, 
APC began a credentialing of advanced practice pharmacists’ pilot programme, to evaluate 
the assessment processes prior to full implementation of the programme. Fifty-three 
pharmacists were selected to participate in the pilot from 138 expressions of interest. This 
ensured diversity by reflecting all areas of pharmacy practice. Forty-three practice portfolios 
were subsequently submitted for evaluation. SHPA acted as a Readiness Support 
Organisation (RSO) providing support to members in the development of their portfolios for 
submission. Fourteen participants were evaluated at Advanced-Stage 2, 1 portfolio was 
unable to be evaluated and 28 participants were evaluated at the credential level (Advanced- 
Stage 3) and are entitled to use the post-nominal Adv. Prac. Pharm. (Advanced Practice 
Pharmacist).  
The rationale, drivers and potential indicators for WDG 4 (see Table 1) provide guidance for 
progress towards meeting the goal. Through the PPDC, which includes representation from 
all national pharmacy organisations, and through additional work completed by SHPA (see 
Figure 1), these indicators have been largely met in the Australian setting.
 Figure 1: SHPA practitioner development pathway linking foundation practice (WDG 2) and 
advanced practice (WDG 4). It demonstrates the enhancement of performance across all five 
APPF Domains as practitioners gain in breadth and depth of experience and skills including 
communication, collaboration, teamwork, leadership, management, critical evaluation, 
research and provision of education through professional development.   
 
  
 Workforce Development Goal 4 
description 
Rationale, drivers and potential 
indicators 
Countries/Territories and Member 
Organizations should have education and 
training infrastructures in place for the 
recognized advancement of the pharmacy 
workforce as a basis for enhancing patient 
care and health system deliverables. 
Need for a common and shared 
understanding of what is meant by 
“specialization” and “advanced practice” in 
context of scope of practice.  
Enhance competency and capability of an 
advanced and expert pharmacist (including 
specializations extending into industry and 
administration settings) for greater 
optimization of complex pharmaceutical 
patient care.  
Systematic use of professional recognition 
programmes/systems as markers for 
advancement and specialization. 
 
Table 1: FIP Workforce Development Goal 4: ‘Advanced and specialist expert practice’ 
description and rationale, drivers and potential indicators [6] 
 
Challenges and opportunities 
After the successful conduct of the 2015 pilot by the APC, a formal programme of advanced 
practice credentialing commenced in March 2016.  Based on the recommendations of the 
pilot, the APC implemented a National Credentialing of Advanced Practice Pharmacists 
programme which incorporated an important role for RSOs and encouraged submission of 
portfolios for assessment at all three stages of the APPF. Unfortunately, a lack of marketing 
and promotion within and outside of the pharmacy profession of the long-term benefits and 
impact of recognised advanced practitioners has seen a poor uptake by the profession for an 
ongoing programme of advanced practice recognition and credentialing. This is despite a 
high proportion of respondents to the survey indicating they considered they were working at, 
or working towards achieving an advanced level of practice. [12]  
Due to sustainability issues with the model the credentialing programme ended in October 
2016. [13] The APPF remains an important framework to describe advanced practice in 
Australia and is being integrated into the national competency standards for the profession, 
rather than as a stand-alone advanced practice framework, to truly reflect the continuum of 
practitioner development. The profession now needs to review the means by which to 
recognise advancement at all stages including the credential level. 
One of the greatest challenges in encouraging pharmacists to seek recognition of more 
advanced pharmacy practice is that tangible benefits are not yet perceived by the majority of 
the profession. [2] In Australia, these challenges include a lack of external drivers for 
pharmacists to pursue formal recognition of more advanced practice, such as links to career 
progression, remuneration, and employer expectations. Clinical Service Capability 
frameworks for some Australian state and territory health services are now mandating breadth 
and depth of pharmacy services required. [14] However, unlike our medical colleagues, the 
criteria for recognition of hospitals as formal training programme sites for pharmacy interns 
and residents are yet to stipulate the requirement for recognised advanced practitioners as 
leaders, managers, educators and evaluators; but this would appear a logical next step in the 
formalisation of pharmacist practitioner and workforce development.  
SHPA and the Pharmaceutical Society of Australia have affirmed their commitment to 
developing advanced practice and progressing professional recognition. [15,16] SHPA is 
currently working in consultation with the pharmacy profession to continue the development 
and recognition of Advanced Practice, to maintain an evidence-based, collaborative approach 
to formalised evaluation, feedback and recognition of practitioners against the APPF. Formal 
recognition of advanced practice is a high priority for SHPA because it builds on SHPA’s 
Residency Programme and other ongoing workforce transformation projects. 
Conclusion 
As a profession we have a new and exciting opportunity to develop and implement a 
sustainable recognition pathway for advanced practice. The successful uptake of the FIP 
WDGs and the development of effective foundation and advanced practice programmes rely 
on collective support from all professional pharmacy leadership bodies and the use of 
professional development frameworks to guide pharmacists along their professional journeys. 
The WDGs reinforce the importance of ensuring competency and capability of foundation, 
advanced and expert pharmacists in all pharmacy sectors for greater optimisation of complex 
pharmaceutical patient care. 
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